| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.9B | $2.8B | $2.6B | $2.3B | $2.3B | $0.6B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.0B | $2.0B | $1.9B | $1.8B | $1.5B | $1.5B | $1.6B | $1.5B |
| Net Income | $1.1B | $1.1B | $0.9B | $1.1B | $1.0B | $0.8B | $0.2B | $1.0B |
| EPS (Basic) | $7.40 | $7.61 | $6.56 | $8.13 | $7.19 | $5.89 | $1.20 | $2.79 |
| EPS (Diluted) | $7.40 | $7.60 | $6.56 | $8.12 | $7.19 | $5.89 | $1.20 | $2.79 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.2B | $21.0B | $20.7B | $20.5B | $19.9B | $19.2B | $19.1B | $18.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.4B | $0.6B | $0.4B | $0.2B | $0.0B | $0.1B |
| Total Liabilities | $10.4B | $9.1B | $8.9B | $9.2B | $9.0B | $8.4B | $8.1B | $7.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $11.6B | — | $11.8B | $11.3B | $10.9B | $10.8B | $11.0B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.6B | $1.6B | $1.4B | $1.2B | $1.2B | $1.3B | $1.3B |
| Investing Cash Flow | $-1.4B | $-1.0B | $-0.9B | $-0.6B | $-0.6B | $-0.2B | $-1.2B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-0.9B | $-0.8B | $-0.7B | $-0.3B | $-0.9B | $-0.2B | $-0.7B |